1
An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-on, Open-Label Study
Condition(s):Bipolar Disorder, ManiaLast Updated:April 26, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Bipolar Disorder, ManiaLast Updated:April 26, 2017Terminated
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:October 27, 2014Completed
Condition(s):Readiness to DischargeLast Updated:September 14, 2016Completed
Condition(s):Opioid-Related Disorders; Drug Addiction; Pregnancy Related; Substance Abuse; Drug Abuse; Neonatal Abstinence Syndrome; Neonatal Opioid Withdrawal Syndrome; Drug Abuse in PregnancyLast Updated:December 19, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.